Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Thalidomide in solid tumours: the resurrection of an old drugStefan Sleijfer, Wim H J Kruit, Gerrit Stoter
Pharmacy World & Science : PWS|December 13, 2005
Side effects of interferon-alpha therapyStefan Sleijfer, Marjolein Bannink, Arthur R Van Gool, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2013
[Revision of the national guideline 'Melanoma']Laetitia Veerbeek, Wim H J Kruit, Johannes H W de Wilt, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2003
IL-12: a promising adjuvant for cancer vaccinationJohanna E A Portielje, Jan Willem Gratama, Heidi H van Ojik, et al.
Pharmacy World & Science : PWS|March 29, 2003
Neuropsychiatric side effects of interferon-alfa therapyArthur R Van Gool, Wim H J Kruit, Frederike K Engels, et al.
Acta Ophthalmologica|January 17, 2018
Pimasertib-associated ophthalmological adverse eventsElon H C van Dijk, Wim H J Kruit, Martine J Jager, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2004
Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patientsMarjolein Bannink, Wim H J Kruit, Arthur R Van Gool, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responsesJohanna E A Portielje, Cor H J Lamers, Wim H J Kruit, et al.
Psychosomatics|January 24, 2008
Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipatedMarjolein Bannink, Wim H J Kruit, Arthur R Van Gool, et al.
Anti-Cancer Drugs|June 19, 2004
Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrationsArthur R Van Gool, Heidi H van Ojik, Wim H J Kruit, et al.
Pageof 3